In addition, rebamipide, a drug for treatment of UC, also attenuates the inflammation in arthritis and gut by rebalancing the Treg/Th17 cells, suppressing TNF-α, IL-17 level and modulating splenic STAT3 activity (Moon et al., 2014; Min et al., 2016). This evidence concerns the gene IL17A and Arthritis.